Company / Total Assets
LEXICON PHARMACEUTICALS, INC. Total Assets History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$185.0M
FY2025
5-year range
$185.0M / $298.4M
FY2021-FY2025
Trend
-38.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 10 years, ranging from $185M in FY2025 to $655M in FY2015.
Based on SEC 10-K filings.
$185M in FY2025 with a 10-year CAGR of -11.9%.
Declined from $229M to $185M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -11.9%
Key checks
Key Insights
- In FY2025, total assets decreased 38.0% year-over-year.
- Peak total assets was recorded in FY2015.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $185.0M | -38.0% |
| FY2024 | $298.4M | +30.1% |
| FY2023 | $229.4M | +18.1% |
| FY2019 | $194.3M | -31.6% |
| FY2018 | $284.1M | -34.9% |
| FY2017 | $436.5M | -8.2% |
| FY2016 | $475.6M | -27.4% |
| FY2015 | $654.8M | +38.9% |
| FY2014 | $471.4M | +71.9% |
| FY2013 | $274.2M | -26.3% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026